MTNB 10-Q: SEC filing
Matinas BioPharma
Filed with the SEC on · accession 0001493152-26-052567
MTNB filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +3.0% by the first close after the filing.
Summary of the filing
Matinas BioPharma filed its Q3 2026 10-Q, reporting financial results for the quarter and nine months ended September 30, 2026, and disclosing a business combination agreement dated July 10, 2026 involving GHPower Inc. and related Series D financing.
Key details
How MTNB stock reacted
Close before
$0.90
Nov 13, 2026
First close after
+3.00%
$0.93
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MTNB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MTNB?
Click hereFrequently asked questions
What did MTNB file with the SEC on Nov 16, 2026?
MTNB filed a 10-Q (SEC filing). Matinas BioPharma filed its Q3 2026 10-Q, reporting financial results for the quarter and nine months ended September 30, 2026, and disclosing a business combination agreement dated July 10, 2026 involving GHPower Inc. and related Series D financing.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did MTNB stock react to this filing?
MTNB closed at $0.90 before the filing and $0.93 on Nov 16, 2026 (+3.00%).
Other MTNB SEC filings
Get alerts when MTNB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days